» Authors » Rohit Aggarwal

Rohit Aggarwal

Explore the profile of Rohit Aggarwal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 217
Citations 3983
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
McKee S, Xenakis J, Makin H, Marshall C, Winnette R, Aggarwal R, et al.
Dermatol Ther (Heidelb) . 2024 Sep; 14(10):2771-2785. PMID: 39264400
Background: Dermatomyositis (DM) is a rare and severely debilitating autoimmune disease that can affect children and adults; however, there is little understanding of the patient-reported experience and uncertainty around validated...
12.
Bae S, Markovic D, Saygin D, Sullivan D, Yamaguchi K, Moghadam-Kia S, et al.
Rheumatology (Oxford) . 2024 Sep; PMID: 39222437
Objective: The 6-min walk test (6MWT) is a simple test widely used to assess sub-maximal exercise capacity in chronic respiratory diseases. We explored the relationship of 6-min walk distance (6MWD)...
13.
Tyagi R, Tripathi S, Aggarwal R, Kumar M
Lung India . 2024 Aug; 41(5):379-380. PMID: 39215983
No abstract available.
14.
Aggarwal A, Chandra T, Ladha P, Mittal S, Haldule S, Nirmal S, et al.
Rheumatol Int . 2024 Aug; 44(11):2293-2299. PMID: 39212691
Anti-synthetase syndrome constitutes a dynamically evolving subset of Idiopathic Inflammatory Myopathy, however, the nomenclature and abbreviations for this syndrome are plagued by heterogeneity, leading to lack of consistency in literature....
15.
Keret S, Lomanto Silva R, Chandra T, Gkiaouraki E, Pongtarakulpanit N, Sriram S, et al.
Rheumatology (Oxford) . 2024 Aug; PMID: 39208289
Objectives: Idiopathic Inflammatory Myopathies (IIM) are rare and characterized by heterogeneous manifestations and clinical trajectories. Utilizing tele-research methods has the potential to improve participant recruitment and advance the understanding of...
16.
Lomanto Silva R, Keret S, Chandra T, Sharma A, Pongtarakulpanit N, Moghadam-Kia S, et al.
Clin Rheumatol . 2024 Aug; 43(10):3157-3166. PMID: 39187744
Introduction: Recruitment for idiopathic inflammatory myopathies (IIM) research is a challenge due to the rarity of the disease and the scarcity of specialized myositis centers. Online recruitment may be a...
17.
Yamaguchi K, Poland P, Zhu L, Moghadam-Kia S, Aggarwal R, Maeno T, et al.
Rheumatology (Oxford) . 2024 Aug; PMID: 39186037
Objectives: Anti-melanoma differentiation-associated gene 5 antibody-positive (MDA5+) dermatomyositis patients exhibit clinical features that vary by geographical and ethnic/genetic distribution. We therefore investigated whether B cell epitope profiles and corresponding clinical...
18.
Christopher-Stine L, Ciesluk A, Chinoy H, Goyal N, Gunter K, Isenberg D, et al.
J Rheumatol . 2024 Aug; 51(12):1198-1207. PMID: 39089831
Objective: Dermatomyositis (DM) symptoms negatively affect the quality of life of individuals living with the disease. Disease-specific, patient-reported outcome (PRO) instruments are needed to assess symptoms important to individuals with...
19.
Paik J, Vencovsky J, Charles-Schoeman C, Wright G, Vleugels R, Goriounova A, et al.
Clin Exp Rheumatol . 2024 Jul; 43(2):354-363. PMID: 39008325
Dermatomyositis (DM) is a rare and debilitating, systemic, autoimmune disease. While heterogenous in presentation and severity, DM is primarily characterised by a spectrum of skin and muscle disease, which may...
20.
Alunno A, Carubbi F, Tan A, Sen P, Cavagna L, Joshi M, et al.
Rheumatol Int . 2024 Jul; 44(9):1725-1731. PMID: 39003346
Notwithstanding the wealth of literature on COVID-19, studies focusing on young adults with autoimmune diseases (AD) are lacking. To determine early (within 7 days) and late (after 7 days) anti-SARS-CoV-2...